Company intelligence / Profile preview

Pharm Ops

Phillipsburg, New Jersey, United Statespharmops.com ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Pharm Ops specializes in the development, manufacturing, and optimization of oral solid dosage forms—tablets, capsules, powders—including controlled release and multi-layered tablets. The company has contributed to the formulation and manufacture of drugs such as Nocturol for ongoing Phase 2 clinical trials. Their facility is GMP licensed with capabilities for both clinical supply and commercial manufacturing.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Wellesley Pharmaceuticals (manufacturing partner for Nocturol)

Beyond the preview

Go deeper on Pharm Ops.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharm Ops.

Explore the full profile